Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 1552 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 1670 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 3264 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 3501 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 3789 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 4269 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 5146 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 5241 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 6192 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 6223 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | 7126 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | Peak area normalized | female | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | BILIVERDIN (M+H)+ | Peak area normalized | male | diabetic | no neuropathy |